Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Boehm

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
British Journal of Pharmacology|March 19, 2016
Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activityF L Scott, B Clemons, J Brooks, et al.
Chemistry & Biology|May 14, 1999
Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3M F Boehm, P Fitzgerald, A Zou, et al.
Schweizerische Medizinische Wochenschrift|July 7, 1979
[Prenatal diagnosis. Review, personal and prospective studies]E Engel, J Empson, D DeLozier, et al.
Schweizerische Medizinische Wochenschrift|July 14, 1979
[Prenatal diagnosis. Review, personal studies and perspectives]E Engel, J Empson, D DeLozier, et al.
Nature|March 27, 1997
Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonistsR Mukherjee, P J Davies, D L Crombie, et al.
Journal of Women'S Health (2002)|April 13, 2010
Economic risk factors for HIV infection among women in rural Haiti: implications for HIV prevention policies and programs in resource-poor settingsM C Smith Fawzi, W Lambert, F Boehm, et al.
Molecular Cancer Therapeutics|April 18, 2009
BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90Karen Lundgren, Hong Zhang, John Brekken, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Design and synthesis of novel RXR-selective modulators with improved pharmacological profilePierre-Yves Michellys, Marcus F Boehm, Jyun-Hung Chen, et al.
Journal of Medicinal Chemistry|May 10, 2007
Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activitySrinivas R Kasibhatla, Kevin Hong, Marco A Biamonte, et al.
Journal of Medicinal Chemistry|September 5, 2003
Design, synthesis, and structure-activity relationship studies of novel 6,7-locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic acidsPierre-Yves Michellys, Robert J Ardecky, Jyun-Hung Chen, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
British Journal of Pharmacology|March 19, 2016
Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activityF L Scott, B Clemons, J Brooks, et al.
Chemistry & Biology|May 14, 1999
Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3M F Boehm, P Fitzgerald, A Zou, et al.
Schweizerische Medizinische Wochenschrift|July 7, 1979
[Prenatal diagnosis. Review, personal and prospective studies]E Engel, J Empson, D DeLozier, et al.
Schweizerische Medizinische Wochenschrift|July 14, 1979
[Prenatal diagnosis. Review, personal studies and perspectives]E Engel, J Empson, D DeLozier, et al.
Nature|March 27, 1997
Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonistsR Mukherjee, P J Davies, D L Crombie, et al.
Journal of Women'S Health (2002)|April 13, 2010
Economic risk factors for HIV infection among women in rural Haiti: implications for HIV prevention policies and programs in resource-poor settingsM C Smith Fawzi, W Lambert, F Boehm, et al.
Molecular Cancer Therapeutics|April 18, 2009
BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90Karen Lundgren, Hong Zhang, John Brekken, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Design and synthesis of novel RXR-selective modulators with improved pharmacological profilePierre-Yves Michellys, Marcus F Boehm, Jyun-Hung Chen, et al.
Journal of Medicinal Chemistry|May 10, 2007
Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activitySrinivas R Kasibhatla, Kevin Hong, Marco A Biamonte, et al.
Journal of Medicinal Chemistry|September 5, 2003
Design, synthesis, and structure-activity relationship studies of novel 6,7-locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic acidsPierre-Yves Michellys, Robert J Ardecky, Jyun-Hung Chen, et al.
Pageof 9